P.J. De Schepper

2.4k total citations · 1 hit paper
53 papers, 2.0k citations indexed

About

P.J. De Schepper is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, P.J. De Schepper has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 16 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in P.J. De Schepper's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Analytical Methods in Pharmaceuticals (8 papers). P.J. De Schepper is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Analytical Methods in Pharmaceuticals (8 papers). P.J. De Schepper collaborates with scholars based in Belgium, United States and Japan. P.J. De Schepper's co-authors include Luc J. Debeer, G P Mannaerts, Joice Thomas, Anne Van Hecken, T. B. Tjandramaga, René Verbesselt, Inge De Lepeleire, L. Verbist, Marleen Depré and A. Buntinx and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

P.J. De Schepper

53 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats.

1979 401 citations G P Mannaerts, Luc J. Debeer et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.J. De Schepper Belgium	20	682	682	338	325	283	53	2.0k
U. C. Dubach Switzerland	25	742 1.1×	245 0.4×	180 0.5×	208 0.6×	243 0.9×	101	2.2k
Marielle Kaplan Israel	32	829 1.2×	310 0.5×	389 1.2×	199 0.6×	294 1.0×	72	4.1k
Anna Rull Spain	26	601 0.9×	205 0.3×	469 1.4×	334 1.0×	204 0.7×	94	2.3k
Plm Jansen Netherlands	17	638 0.9×	105 0.2×	167 0.5×	412 1.3×	247 0.9×	44	2.1k
Eero A. Sotaniemi Finland	28	592 0.9×	174 0.3×	196 0.6×	198 0.6×	947 3.3×	128	2.7k
Anna Davoli Italy	28	670 1.0×	276 0.4×	151 0.4×	424 1.3×	53 0.2×	51	2.7k
M Burstein France	13	662 1.0×	286 0.4×	153 0.5×	561 1.7×	171 0.6×	67	4.1k
Michael A. Wynalda United States	20	507 0.7×	605 0.9×	41 0.1×	250 0.8×	251 0.9×	33	1.7k
Carey J. Ng United States	13	369 0.5×	286 0.4×	897 2.7×	98 0.3×	110 0.4×	13	1.6k
Mitchell N. Cayen China	21	473 0.7×	239 0.4×	56 0.2×	231 0.7×	349 1.2×	77	1.6k

Countries citing papers authored by P.J. De Schepper

Since Specialization

Citations

This map shows the geographic impact of P.J. De Schepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.J. De Schepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.J. De Schepper more than expected).

Fields of papers citing papers by P.J. De Schepper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.J. De Schepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.J. De Schepper. The network helps show where P.J. De Schepper may publish in the future.

Co-authorship network of co-authors of P.J. De Schepper

This figure shows the co-authorship network connecting the top 25 collaborators of P.J. De Schepper. A scholar is included among the top collaborators of P.J. De Schepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.J. De Schepper. P.J. De Schepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Cuyue, Magang Shou, Thomas H. Rushmore, et al.. (2001). In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics. Pharmacogenetics. 11(3). 223–235. 96 indexed citations

Hecken, Anne Van, Jules I. Schwartz, Marleen Depré, et al.. (2000). Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers. The Journal of Clinical Pharmacology. 40(10). 1109–1120. 285 indexed citations

Hecken, Anne Van, Marleen Depré, A. Verbruggen, et al.. (1998). Effect of Clopidogrel on Naproxen-Induced Gastrointestinal Blood Loss in Healthy Volunteers. Drug metabolism and drug interactions. 14(3). 193–206. 19 indexed citations

Tjandramaga, T. B., et al.. (1996). Liquid chromatographic determination of total celiprolol or (S)-celiprolol and (R)-celiprolol simultaneously in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 683(2). 231–236. 10 indexed citations

Michaelis, Karl, et al.. (1996). Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide. European Journal of Clinical Pharmacology. 51(3-4). 339–344. 1 indexed citations

Friedman, Beth S., Anne Van Hecken, Inge De Lepeleire, et al.. (1994). Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase—activating protein inhibitor. Clinical Pharmacology & Therapeutics. 56(1). 22–30. 16 indexed citations

Hecken, Anne Van, Jules I. Schwartz, T. B. Tjandramaga, et al.. (1994). Plasma concentrations and effect on testosterone metabolism after single doses of MK-0434, a steroid 5 alpha-reductase inhibitor, in healthy subjects. European Journal of Clinical Pharmacology. 46(2). 123–126. 8 indexed citations

Hecken, Anne Van, René Verbesselt, Marleen Depré, et al.. (1993). Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin. European Journal of Clinical Pharmacology. 45(3). 291–293. 6 indexed citations

Margolskee, Dorothy J., John Y.‐K. Hsieh, Anne Van Hecken, et al.. (1992). Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man. European Journal of Clinical Pharmacology. 43(4). 427–430. 7 indexed citations

10.

Schepper, P.J. De, Julianne Imperato‐McGinley, Anne Van Hecken, et al.. (1991). Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5α-reductase inhibitor. Steroids. 56(9). 469–471. 28 indexed citations

11.

Tjandramaga, T. B., et al.. (1990). Determination of 5-aminosalicylic acid (5-ASA) and acetyl-5-ASA in biological media by high performance liquid chromatography. European Journal of Pharmacology. 183(6). 2384–2385. 2 indexed citations

12.

Lepeleire, Inge De, Anne Van Hecken, René Verbesselt, et al.. (1990). Lack of interaction between famotidine and warfarin.. PubMed. 10(3). 167–71. 6 indexed citations

13.

Hecken, Anne Van, René Verbesselt, T. B. Tjandramaga, & P.J. De Schepper. (1989). Pharmacokinetic interaction between indomethacin and diflunisal. European Journal of Clinical Pharmacology. 36(5). 507–512. 14 indexed citations

14.

Lepeleire, Inge De, Anne Van Hecken, René Verbesselt, T. B. Tjandramaga, & P.J. De Schepper. (1988). Comparative oral pharmacokinetics of fleroxacin and pefloxacin. Journal of Antimicrobial Chemotherapy. 22(2). 197–202. 11 indexed citations

15.

Lepeleire, Inge De, Anne Van Hecken, René Verbesselt, et al.. (1988). Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers. European Journal of Clinical Pharmacology. 34(5). 465–468. 16 indexed citations

16.

Mannaerts, G P, Luc J. Debeer, Joice Thomas, & P.J. De Schepper. (1979). Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats.. Journal of Biological Chemistry. 254(11). 4585–4595. 401 indexed citations breakdown →

17.

Debeer, Luc J., Joice Thomas, P.J. De Schepper, & G P Mannaerts. (1979). Lysosomal triacylglycerol lipase and lipolysis in isolated rat hepatocytes.. Journal of Biological Chemistry. 254(18). 8841–8846. 63 indexed citations

18.

Vickers, S., et al.. (1978). EVALUATION OF SUCCINIMIDOETHYL AND PIVALOYLOXYETHYL ESTERS AS PROGENITORS OF METHYLDOPA IN MAN, RHESUS MONKEY, DOG, AND RAT. Drug Metabolism and Disposition. 6(6). 640–646. 21 indexed citations

19.

Verbeeck, Roger K., T. B. Tjandramaga, R. Verberckmoes, & P.J. De Schepper. (1976). BIOTRANSFORMATION AND EXCRETION OF LORAZEPAM IN PATIENTS WITH CHRONIC RENAL FAILURE. British Journal of Clinical Pharmacology. 3(6). 1033–1039. 55 indexed citations

20.

Mannaerts, G P, et al.. (1974). Metabolic effects of hypoglycemic sulfonylureas—IV. Biochemical Pharmacology. 23(2). 239–250. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact